Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial
Background. The optimal combination of chemotherapy with radiation therapy for treatment locally advanced non-small cell lung cancer (NSCLC) remains an open issue. This randomized phase II study compared gemcitabine in two different schedules and cisplatin - as induction chemotherapy, followed by ra...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2014-12-01
|
Series: | Radiology and Oncology |
Subjects: | |
Online Access: | https://doi.org/10.2478/raon-2014-0026 |
_version_ | 1818666717854826496 |
---|---|
author | Vrankar Martina Zwitter Matjaz Bavcar Tanja Milic Ana Kovac Viljem |
author_facet | Vrankar Martina Zwitter Matjaz Bavcar Tanja Milic Ana Kovac Viljem |
author_sort | Vrankar Martina |
collection | DOAJ |
description | Background. The optimal combination of chemotherapy with radiation therapy for treatment locally advanced non-small cell lung cancer (NSCLC) remains an open issue. This randomized phase II study compared gemcitabine in two different schedules and cisplatin - as induction chemotherapy, followed by radiation therapy concurrent with cisplatin and etoposid. |
first_indexed | 2024-12-17T06:08:58Z |
format | Article |
id | doaj.art-9dd733feefa743f59f11d097d9dcdf77 |
institution | Directory Open Access Journal |
issn | 1581-3207 |
language | English |
last_indexed | 2024-12-17T06:08:58Z |
publishDate | 2014-12-01 |
publisher | Sciendo |
record_format | Article |
series | Radiology and Oncology |
spelling | doaj.art-9dd733feefa743f59f11d097d9dcdf772022-12-21T22:00:42ZengSciendoRadiology and Oncology1581-32072014-12-0148436938010.2478/raon-2014-0026raon-2014-0026Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trialVrankar Martina0Zwitter Matjaz1Bavcar Tanja2Milic Ana3Kovac Viljem4Institute of Oncology Ljubljana, Ljubljana, SloveniaInstitute of Oncology Ljubljana, Ljubljana, Slovenia / Faculty of Medicine, University of Maribor, SloveniaClinical Radiology Institute, University Medical Centre Ljubljana, SloveniaInstitute of Oncology Ljubljana, Ljubljana, SloveniaInstitute of Oncology Ljubljana, Ljubljana, SloveniaBackground. The optimal combination of chemotherapy with radiation therapy for treatment locally advanced non-small cell lung cancer (NSCLC) remains an open issue. This randomized phase II study compared gemcitabine in two different schedules and cisplatin - as induction chemotherapy, followed by radiation therapy concurrent with cisplatin and etoposid.https://doi.org/10.2478/raon-2014-0026induction chemotherapygemcitabinenon-small cell lung cancerradiation therapyconcurrent chemoradiationrandomized clinical trial |
spellingShingle | Vrankar Martina Zwitter Matjaz Bavcar Tanja Milic Ana Kovac Viljem Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial Radiology and Oncology induction chemotherapy gemcitabine non-small cell lung cancer radiation therapy concurrent chemoradiation randomized clinical trial |
title | Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial |
title_full | Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial |
title_fullStr | Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial |
title_full_unstemmed | Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial |
title_short | Induction gemcitabine in standard dose or prolonged low-dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non-small cell lung cancer: a randomized phase II clinical trial |
title_sort | induction gemcitabine in standard dose or prolonged low dose with cisplatin followed by concurrent radiochemotherapy in locally advanced non small cell lung cancer a randomized phase ii clinical trial |
topic | induction chemotherapy gemcitabine non-small cell lung cancer radiation therapy concurrent chemoradiation randomized clinical trial |
url | https://doi.org/10.2478/raon-2014-0026 |
work_keys_str_mv | AT vrankarmartina inductiongemcitabineinstandarddoseorprolongedlowdosewithcisplatinfollowedbyconcurrentradiochemotherapyinlocallyadvancednonsmallcelllungcancerarandomizedphaseiiclinicaltrial AT zwittermatjaz inductiongemcitabineinstandarddoseorprolongedlowdosewithcisplatinfollowedbyconcurrentradiochemotherapyinlocallyadvancednonsmallcelllungcancerarandomizedphaseiiclinicaltrial AT bavcartanja inductiongemcitabineinstandarddoseorprolongedlowdosewithcisplatinfollowedbyconcurrentradiochemotherapyinlocallyadvancednonsmallcelllungcancerarandomizedphaseiiclinicaltrial AT milicana inductiongemcitabineinstandarddoseorprolongedlowdosewithcisplatinfollowedbyconcurrentradiochemotherapyinlocallyadvancednonsmallcelllungcancerarandomizedphaseiiclinicaltrial AT kovacviljem inductiongemcitabineinstandarddoseorprolongedlowdosewithcisplatinfollowedbyconcurrentradiochemotherapyinlocallyadvancednonsmallcelllungcancerarandomizedphaseiiclinicaltrial |